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Summary.-The peripheral blood lymphocyte count has been measured in 74 cases
of histologically proven carcinoma of the gastrointestinal tract. The count has been
correlated with the pathological stage of tumour spread and the patient's delayed
hypersensitivity response to 2.4 dinitrochlorobenzene (DNCB). A statistically
significant correlation was found between the peripheral blood lymphocyte count
and the response to DNCB. There was linear association between the extent of
spread of the tumours and the lymphocyte count. Those patients withlowperipheral
blood lymphocyte counts tended to have more advanced tumours and a poor response
to DNCB. The possible causes of this lymphopenia are discussed.
TREATMENT of gastrointestinal cancer
has been disappointing, in that despite
more aggressive and radical surgical
techniques there has been no concomitant
improvement in survival figures. This
has stimulated a search for adjuvant
forms of therapy which will assist in
the eradication of malignant cells from
the body. Much interest has been con-
centrated on the possible role of immuno-
therapy. This interest has been accentu-
ated by the demonstration of peripheral
blood lymphocyte induced tumour cell
killing. This may be due to the presence
of tumour specific transplantation anti-
gens (Hellstr6m et al., 1971). It has
been suggested that these antigens may
be able to excite an immune response
in the host. which will in turn restrict
the proliferation of the tumour (Morton,
1972). Cellular immunity is believed to
be the more important factor in the
immune response to neoplasia and a
relationship between cellular immunity
and prognosis has been demonstrated in
patients with gastrointestinal cancer
(Bone, Appleton and Venables, 1973).
The small lymphocvte has a very impor-
tant role in the cellular immune response
in the homograft reaction and in the
response to malignant disease. Sensitized
cells have been shown to have a cytotoxic
effect on malignant cells in vitro (Hell-
str6m and Hellstrom, 1970). Attempts at
adoptive immunization by infusing sen-
sitized lymphocvtes into tumour bearing
patients have shown that it is possible
to obtain some degree of remission of
the disease (Woodruff and Nolan. 1963:
Symes, Riddell and Immelman, 1968).
This present investigation was de-
signed to study the relationship of cellular
immunity to the peripheral blood lympho-
cyte count in patients with gastrointestinal
cancer.
MATERIALS AND METHODS
Patients-.Seventy-four patients with his-
tologically proven carcinoma of the gastro-
intestinal tract were studied. Table I shows
TABLE I. The Anatomical Sites of the
Tumours Studied
Sites of carcinoma No.
Rectum 26
Colon 20
Stomach 19
Oesophagus 6
Pancreas 3G. BONE AND I. LAUDER
the sites of the various neoplasmns. The
patient,s' ages ranged from 37 to 88 years
(mean age 63 years); 47 were male and 27
female. Any patients who had received
cytotoxic drugs, radiotherapy and cortico-
steroids wNere excluded, as were those who
-were uraemic or who had evidence of active
infection. None of the patients studied wAas
suffering from diseases associated with a
lymphocytosis, such as infectious mono-
nucleosis or chronic lymphatic leukaemia.
Seventy-two patients from the same
hospital population were studied as controls.
Their ages ranged from 34 to 81 years
(mean age 64 years); 45 were male and 27
female. All these patients satisfied the
same conditions as applied to t,he patients
with cancer. All had benign conditions
with no recent, evidence or past history of
malignant disease.
DNCB sensitization and testing.-Cellular
immunity was assessed by the patient's
ability to produce a delayed hypersensitivity
response to the potent sensitizer 2.4 dinitro-
chlorobenzene (DNCB). The patients with
cancer were sensitized by the application
of 4000 jug of DNCB, dissolved in acetone
and applied to a 3 cm2 area of skin on the
palmar aspect of the forearm. An occlusive
polyethylene dressing -as left in position over
the site for 4 days.
Sensitivity tests were carried out by
applying 4 Al patch test squares (IMECO
A.B. Stockholm) each impregnated with a
different strength of DNCB dissolved in
acetone (200, 100, 40 and 2 Mtg). These
patch test squares wAere applied to the
opposite forearm at lea-st 14 days after
sensitization. The tests were read at 48 h.
A patch test wAas scored positive if there
was erythema and induration under the
patch test square at this time. Induration
was scored as being present or absent, and
if present the skin test was scored as positive.
It w-as detected by observation and palpation
of the area, although its exact! extent was
not measured. The presence of erythema
without induration and induration with-
out erythema were scored as negative.
Patients were graded according to their
ability to respond as followis:
Grade I = Negative
Grade II = Sensitive to 200 or 100 jtg
DNCB
Grade III = Sensitive to 40 Mg DNCB
Grade IV = Sensitive to 2 pg DNCB
Of the 74 patients w%ith cancer studied,
52 had their responses to DNCB measured.
Lymphocyte count.-The peripheral blood
lymphocyte count was measured by first
counting the total white cell count on a
Model-S Coulter Counter followi-ed by a
differential white cell count on May-Grin-
wald-Giemsa stained slides. Results were
expressed as lymphocytes per mm3.
Pathological grading. All the patients
with cancer were submitted to laparotomy.
The extent of their disease was staged
pathologically according to the following
PATIENTS WITH
CANCER
20 r
C,,
C
)
'4-
0
co; 0
z
15H
101-
5
II III IV
DNCB Grading
FIG. 1. Delayed hypersensitivity responses to DNCB in 52 canicer patients. I I I I
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scheme: Stage A = localized to the mucosa
ofthe organ concerned; Stage B = infiltrating
full thickness of the organ wall and in some
instances into the surrounding tissues but
with no evidence of lymph node or distal
spread; Stage C = Evidence of lymph node
involvement but no evidence of distal
metastases; Stage D- Distal metastases
present.
RESITLTS
Figure 1 shows the distribution of
the responses to DNCB in the patients
with malignant disease. Although 25O%
were anergic. a high proportion of these
patients (400h) showed a good response.
i.e. Crade IV. Previous workers have
reported the ability to sensitize up to
950/ of a normal population (Eilber and
AMorton. 1970). and this has been con-
firmed in 20 control patients who had
their DNCB responses assessed (Fig. 2).
Figure 3 shows the distribution of
l)eripheral blood lymphocyte counts in
the control group and in the group with
nmalignant disease. Despite substantial
overlap there is a statistically highly
significant difference in the mean values
in these two groups (P < 0-01). with the
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mean value 577 lower in the cancer
group.
Figure 4 shows the relationship of
peripheral blood lymphocyte count with
the DNCB grading in patients with
malignant disease. The mean lympho-
cyte count increased with increasing
sensitivitv to DNCB. This is a statistic-
ally highly significant relationship
(P < 0.001) and the difference in mean
lymphocyte count for the 4 DNCB
grades is ascribable to a linear trend by
analysis of variance (P < 0-001).
The relationship of lymphocyte count
to DNCB grading is given approximately
bv the formula:
L - 430 (1 + G). where L is the
peripheral blood lymphocyte
count per mm3 and C is the
DNCB grade.
Figure 5 shows the comparison of the
peripheral blood lymphocyte couint with
the pathological staging of the t-uLours
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FIG. 2. Delayed hypersensitivity responses to
DNCB in 20 control patients.
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FIG. 3. Peripheral blood lymphocyte counts in
cancer and control patients.
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FIG. 5.--Relationship of the peripheral blood lymphocyte count to the extent of tumour spread in
cancer patients.
studied. No significant conclusions can
be drawn from the Stage A group because
of the small numbers involved. How-
ever, in the other stages it is possible to
demonstrate a statistically significant
depression of mean lymphocyte counts
with increased tumour progression
(P < 001). Once again the differences
in the mean lymphocyte counts in the
three stages of tumour progression is
ascribable to a linear trend by analysis
of variance (P < 0.01).
Table II shows the correlation of
DNCB grading of cancer )atients with
the pathological staging of their tumours.
For the purpose of statistical analysis
the patients have been allocated to 4
groups, depending on their ability to
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TABLE II. The Relationship of DNCB
Grading toPathological Staging
Pathological staging
Unfavourable Favourable
DNCB grading (C + D) (A + B)
Poor (I & II) 22 1
Good (III & IV) 11 17
P = 0 - 000022 (Fisher's exact test).
respond to DNCB and on the stage of
progression of their tumours. DNCB
responses are separated into "good "
(Grade III and IV) and " poor " (Grade I
and II) responses and the tumours without
evidence of lymphatic or distant meta-
stases (Stage A and B) are designated
favourable " stages whereas patients
with metastases (C and D) are designated
unfavourable " stages.
x2 analysis of the resulting table
shows a statistically highly significant
relationship between good response to
DNCB and favourable pathological stag-
ing (P 0-000022, Fisher's Exact Test).
DISC1USSION
This study has demonstrated a statis-
tically significant relationship between
malignant disease of the gastrointestinal
tract and a depressed delayed hyper-
sensitivity (DH) response to DNCB.
This depression of the DH response is
in turn statistically correlated with a
reduction in the number of circulating
peripheral blood lymphocytes. The de-
pression of the DH response to DNCB
in cancer patients is well recognized
(Bone et al.. 1973; Krant et al.. 1968).
In the study by Krant et al. (1968) it
was not possible to relate DNCB sensi-
tivity to the number of circulating
lymphocytes in bronchogenic carcinoma
patients. They were able to show a
deepening lvmphocytopenia with pro-
gression of the tumours and this was
correlated with survival time. Their
failure to demonstrate a correlation of
DNCB sensitivity with lvmphocvte count
could have been due to the use of a
single dose of DNCB, as they noted that
it was not possible to sensitize " a fair
percentage (10-15 o) of normal people ".
In the present study only one control
patient out of 20 failed to react to
DNCB. This depression of the DH
response to DNCB in the cancer patients
could be due to either a central defect
in cellular immunity or a failure in the
peripheral mechanism by means of which
inflammatory cells accumulate at the site
of the response. There is evidence that
cancer patients may not be able to
niount an inflammatory response to non-
specific irritants such as croton oil (John-
son, Maibach and Salmon, 1971).
Both Riesco (1970) and Bill and
Morgan (1970) have also demonstrated
a correlation between cancer curability
and the total number of peripheral blood
lymphocytes. McCredie. Inch and Suther-
land (1973). in a study of breast cancer,
were unable to detect an association
between prognosis and lymphocyte count.
Our findings support the former view
and we have also previously published
results showing that lymphocytes from
patients with gastrointestinal cancer show
a diminished response to phytohaem-
agglutinin (Lauder and Bone, 1973). The
combination of a reduction in number and
functional capacity could reasonably be
expected to increase the rate ofprogression
of the neoplasm. Several studies have
demonstrated that in a varietv of malig-
nant neoplasms lvmphocytic infiltration
of the tumour is associated with longer
survival (Black, Opler and Speer, 1.956;
Berg. 1959; Lauder and Aherne. 1972).
The correlation between peripheral
blood lymphocyte count and the delayed
hypersensitivity response to DNCB is
not surprising as delayed hypersensitivity
reactions are known to be predominantly
mediated via the snmall lymphocyte. Turk
and his co-workers have shown that 80O
of the cells participating in the skin
response to DNCB are lymphocytes and
2000 are macrophages (Turk. Rudner
and Heather, 1966; Turk, Heather and
Diengdoh. 1966). Since both the DNCB
grade and the lymphocyte count show a
statistically significant correlation withG. BONE AND I. LAUDER
the extent of tumour progression, the
lymphocyte count and DNCB sensitivity
would be expected to be correlated. We
have no evidence that the depression in
the DH response to DNCB is necessarily
directly related to the peripheral blood
lymphocyte count and there may be
several indirect factors involved. How-
ever, Waksman and Arbouys (1960) have
shown that the induction of a lympho-
cytopenia by the administration of a
heterologous antilymphocyte antibody
before skin testing will inhibit the appear-
ance of some forms of hypersensitivity
responses. The biological significance of
the degree of responsiveness to DNCB is
further supported by the demonstration
of Eilber and Morton (1970) of a cor-
relation between poor DNCB response and
recurrence oftumours after surgery.
When assessing cell mediated im-
munity in malignant disease, one must
attempt to distinguish between the pri-
mary effect of an impaired immune
system on the growth of the tumour and
the converse secondary effect ofadvancing
tumour growth on the immune system
itself. It is possible that depression of
the circulating peripheral blood lympho-
cyte count and cellular immunity are a
direct result of increasing tumour mass.
For example, patients with terminal
disease may be in an advanced state of
malnutrition, which has been shown to
depress cell mediated immunity (Edelman
et al., 1973). This is a pertinent factor
but in this study none of the patients
was grossly cachectic and several patients
with advanced disease and depressed
cellular immunity were in fact obese.
Using the closely related sensitizing agent
2.4-dinitro-1-fluorobenzene (DNFB) Levin
et al. (1964) concluded that the delayed
hypersensitivity response was significantly
lower in the cancer patients than in
either healthy controls or patients with
debilitating non-neoplastic disease.
Other factors capable of causing a
depression of lymphocyte production
could also be operating. For example,
patients under stress have a high circulat-
ing corticosteroid level, which in turn
can produce thymic atrophy and reduced
lymphocyte counts (Valentine, Craddock
and Lawrence, 1948). Widespread meta-
static disease could reduce the production
of lymphocytes because of bone marrow
and lymph node replacement. There
may be other factors which act by causing
increased destruction of lymphocytes.
For example, there could be a toxin
liberated by the growing tumour which
could destroy lymphocytes or stop their
proliferation. Similarly, free antigen may
be released from the tumour and be
present free in the circulation (Currie,
1973). Lymphocytes sensitized to this
antigen may well, on second contact,
become involved in an antigen-antibody
reaction with the possibility of lysis of
the lymphocytes (Favour, 1957; Dwyer
and MacKay, 1970).
Sensitized lymphocytes could also be
removed from the circulation by migration
into the neoplasm and attachment to
tumour cells. The presence in some
tumours of large numbers of lympho-
cytes has alreadv been mentioned and
has been demonstrated by several groups
of workers (Black et al., 1956; Berg,
1959; Lauder and Aherne, 1972). In the
gastrointestinal tract lymphocyte infiltra-
tion may also reflect nonspecific factors
such as ulceration and infection. Zatz,
White and Goldstein (1973) have shown
that during tumorigenesis in mice signifi-
cant numbers of circulating lymphocytes
were trapped in lymph nodes draining
the tumour. This process may have a
counterpart in the human.
We may therefore conclude that in
patients with malignant disease there
may be several factors co-operating to
reduce the number of lymphocytes by
decreased production or increased destruc-
tion and utilization.
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